We are live on ! Find out more
ORGS

Orgenesis Inc. Common Stock

Delisted

ORGS was delisted on the 18th of October, 2024.

14 hedge funds and large institutions have $3.7M invested in Orgenesis Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

10% less capital invested

Capital invested by funds: $4.12M → $3.7M (-$418K)

22% less funds holding

Funds holding: 1814 (-4)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
14
Holders Change
-4
Holders Change %
-22.22%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
5
Calls
Puts
Net Calls
Net Calls Change

ORGS Hedge Fund Activity: Q4 2019 in Review

14 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q4 2019, worth a combined $3.7M — down 10% from $4.12M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ORGS and 1 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $47.4K. The largest seller was Venator Capital Management, exiting entirely with an estimated $685K sold.

  • 14 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q4 2019, down from 18 in Q3 2019.
  • Funds reported $3.7M of Orgenesis Inc. Common Stock stock for Q4 2019, down 10% quarter-over-quarter.
  • 1 fund opened new Orgenesis Inc. Common Stock positions in Q4 2019 and 5 closed out, a net change of -4 holders.
  • The largest Orgenesis Inc. Common Stock buyer in Q4 2019 was Renaissance Technologies, an estimated $47.4K added.
  • The largest Orgenesis Inc. Common Stock seller in Q4 2019 was Venator Capital Management, an estimated $685K sold.

Based on aggregated 13F filings for Q4 2019.